To date, the only procedure that has demonstrated to shorten neutropenia is so called “haplo-cord” transplants in which CD34+ selected cells from the mobilized peripheral blood of an HLA-mismatched third-party donor are co-infused with the UCB unit. This evidence concerns the gene CD34 and neutropenia.